Sanofi poised to make offer for Genzyme

Chris Viehbacher, the chief executive of Sanofi-Aventis of France, on Thursday left open the option of a $19bn takeover of US biotech company Genzyme as he unveiled second-quarter...

Read full article on: FT Alphaville » M&A

This entry was posted on Thursday, July 29th 2010 at 21:40 and is filed under Latest Headlines.